In vitro rapid and quantitative cell-based assay is demanded to verify the efficacy prediction of cancer drugs since a
cancer patient may have unconventional aspects of tumor development. Here, we show the rapid and non-label
quantitative verifying method and instrumentation of apoptosis for cell cycle-arrest type cancer drugs (Roscovitine and
D-allose) by reaction analysis of living liver cancer cells cultured on a sensor chip with a newly developed high precision
(50 ndeg s-1 average fluctuation) surface plasmon resonance (SPR) sensor. The time-course cell reaction as the SPR
angle change rate for 10 min from 30 min cell culture with a drug was significantly related to cell viability. By the
simultaneous detection of differential SPR angle change and fluorescence by specific probes using the new instrument,
the SPR angle was related to the nano-order potential decrease in inner mitochondrial membrane potential. The results
obtained are universally valid for the cell cycle-arrest type cancer drugs, which mediate apoptosis through different cell-signaling
pathways, by a liver cancer cell line of Hep G2 (P<0.001). This system towards the application to evaluate
personal therapeutic potentials of drugs using cancer cells from patients in clinical use.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.